Clinical trial
Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine
NCT00277147 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00277147 |
|---|---|
| Title | Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine |
| Official title | Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine, Phase 1 Trial in Adults at NIH CC |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Typhoid Fever |
| Intervention type | Drug |
| Interventions | BB IND 6989 |
| Enrollment | 25 |
| Start date | Jan 9, 2006 |
| Completion | Sep 17, 2008 |
| First posted | Jan 13, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: